TGFB1 and melanoma: And BRAF-V600 inhibitor can suppress the activation of TGF-β signaling via dephosporylation of TFEB, while TFEB phosphorylation and TGF-β upregulation play a pro-tumorigenic role in BRAF inhibitor resistant melanoma [48].